State Street Corp Celcuity Inc. Call Options Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CELC
# of Institutions
111Shares Held
31.7MCall Options Held
40.2KPut Options Held
21.5K-
Baker Bros. Advisors LP New York, NY5.45MShares$420 Million0.74% of portfolio
-
Bvf Inc San Francisco, CA3.47MShares$267 Million1.82% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.01MShares$232 Million3.12% of portfolio
-
Nea Management Company, LLC Timonium, MD2.29MShares$177 Million2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.67MShares$128 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $1.15B
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...